Moon Hee Jung, Kim Eun-Kyung, Kwak Jin Young, Yoon Jung Hyun
1 All authors: Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Yonsei-ro 50, Seodaemun-gu, Seoul 120-752, Republic of Korea.
AJR Am J Roentgenol. 2016 Apr;206(4):823-8. doi: 10.2214/AJR.15.15351. Epub 2016 Mar 9.
The purpose of this study is to investigate when repeat ultrasound (US)-guided fine-needle aspiration (FNA) for thyroid nodules 10 mm or larger with initial nondiagnostic results due to inadequate or unsatisfactory specimen could be performed.
A total of 228 nodules 10 mm or larger with initial nondiagnostic results in 223 patients were classified into three groups according to the first follow-up US or US-guided FNA intervals after the initial US-guided FNA: within 3 months (group 1), 3-9 months (group 2), and more than 9 months (group 3). Nodules were classified according to size change. The malignancy detection rate and clinicopathologic characteristics were compared among the three groups.
Seven nodules (3.1%) were malignant, and their cancer stages were the same as that determined at the initial US-guided FNA. Malignancy detection rates, as well as tumor size, extrathyroidal extension, and lymph node metastasis at pathologic analysis, were not significantly different among the three groups. Thirteen of 228 nodules (5.7%) showed increased size at a mean (± SD) of 34.5 ± 25.1 months (range, 10.7-84.7 months) after initial US-guided FNA, and one of the 13 nodules (7.7%) was malignant, a minimally invasive follicular carcinoma without lymph node metastasis found at 63.2 months. Of 177 nodules without change, six papillary thyroid carcinomas (3.4%) were found at a mean of 10.4 months. None of the 38 nodules with decreased size during a mean follow-up interval of 26.1 ± 19.8 months (range, 2.8-79.5 months) was malignant.
Repeat US-guided FNA for initial nondiagnostic thyroid nodules after 10.7 months can reduce unnecessary repeat US-guided FNAs without progression of malignancy.
本研究旨在探讨对于初始因标本不足或不满意而诊断不明确的10毫米及以上甲状腺结节,何时可进行重复超声(US)引导下细针穿刺活检(FNA)。
将223例患者中228个初始诊断不明确的10毫米及以上结节,根据初次US引导下FNA后的首次随访超声或US引导下FNA间隔时间分为三组:3个月内(第1组)、3至9个月(第2组)、9个月以上(第3组)。根据大小变化对结节进行分类。比较三组的恶性肿瘤检出率及临床病理特征。
7个结节(3.1%)为恶性,其癌症分期与初次US引导下FNA时确定的分期相同。三组之间的恶性肿瘤检出率以及病理分析时的肿瘤大小、甲状腺外侵犯和淋巴结转移情况无显著差异。228个结节中有13个(5.7%)在初次US引导下FNA后平均(±标准差)34.5±25.1个月(范围10.7 - 84.7个月)时大小增加,其中13个结节中有1个(7.7%)为恶性,是在63.2个月时发现的无淋巴结转移的微小浸润性滤泡癌。177个大小无变化的结节中,平均在10.4个月时发现6个甲状腺乳头状癌(3.4%)。在平均随访间隔26.1±19.8个月(范围2.8 - 79.5个月)期间大小减小的38个结节中,无一为恶性。
对于初始诊断不明确的甲状腺结节,在10.7个月后进行重复US引导下FNA可减少不必要的重复US引导下FNA,且不会导致恶性肿瘤进展。